KCNE1/IsK Blocking Peptide, BLP-PC163
4.9 (531) · $ 136.50 · In stock
A Blocking Peptide for Anti-KCNE1/IsK Antibody
Structural Basis of Human KCNQ1 Modulation and Gating - ScienceDirect
The emerging landscape of peptide-based inhibitors of PCSK9 - ScienceDirect
A constitutively open potassium channel formed by KCNQ1 and KCNE3
BK channel agonist represents a potential therapeutic approach for lysosomal storage diseases
Efficient peptide ligation between allyl-protected Asp and Cys followed by palladium-mediated deprotection - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC01965G
LncRNA KCNQ1OT1 activated by c-Myc promotes cell proliferation via interacting with FUS to stabilize MAP3K1 in acute promyelocytic leukemia
PK - Liquid Peptides
Gain and loss of TASK3 channel function and its regulation by novel variation cause KCNK9 imprinting syndrome, Genome Medicine
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
Pcsk9 blocking peptide - MyBioSource
The emerging landscape of peptide-based inhibitors of PCSK9 - ScienceDirect
D1 Dopamine Receptor Blocking Peptide, BLP-DR001
